GHK-Cu is a copper-binding peptide studied in skin and wound biology. Research findings depend on the formulation and do not prove a benefit from a product labelled CU50.
CU50 should not be treated as confirmed GHK-Cu without a complete verified label.
CU50 may be presented as GHK-Cu, but the code alone does not confirm that.
Reported benefits, not product promises
Personal stories are anecdotal. They cannot show whether a product caused a change, how often it happens or what the risks are.
The cited GHK-Cu work is laboratory and animal research, not proof of a clinical skin, hair, or wound benefit. It also cannot establish what a CU50-labelled product contains.
GHK-Cu is a copper-binding tripeptide researched in wound and skin biology. CU50 does not confirm that ingredient, its copper complex, concentration, route or formulation. The studies below therefore describe GHK-Cu research, not a conclusion about a CU50-labelled product.
In 1993, researchers implanted wound chambers under rats' skin and compared GHK-Cu with saline. GHK-Cu was associated with concentration-dependent increases in collagen and other extracellular-matrix measures. This is an animal model, not a clinical wound-treatment trial.
GHK-Cu in rat experimental wounds (1993)A 2023 laboratory study treated human skin cells and skin samples studied outside the body with GHK-Cu plus low-molecular-weight hyaluronic acid. At the selected 1:9 ratio, collagen IV rose 25.4-fold in cells and 2.03-fold in ex-vivo skin. It was not a clinical study or a test of GHK-Cu alone.
GHK-Cu and hyaluronic acid in fibroblast and ex-vivo skin tests (2023)The research is mainly mechanistic, animal and laboratory work. Confirming a label's identity and formulation remains essential before attributing any GHK-Cu finding to it.
Research topics are not a promise of benefits.
GHK-Cu is a recognised research name used in skin-related studies.
CU50 does not identify route, concentration, product quality, clinical benefit or safety for a particular product.
This is not a complete list of risks or a personal safety assessment.
Keep its packaging and ingredient information. Check the formulation, instructions and supplies together. An unidentified product cannot be made safe by an online dose calculation.
Before mixing: checks & suppliesMedsafe’s warning is particularly relevant where an unapproved product is presented for injection.
“Research purposes only” is not a legal exemption or a safety guarantee. This guide is for research and educational purposes only and does not recommend taking this substance.
Read Medsafe’s warningThe things you might be wondering.
It is a copper-binding peptide studied in skin and wound biology.
No. The code is not enough to verify identity or formulation.
There is no universal safe dose. Do not use an unverified formulation; discuss any treatment with a clinician and a confirmed regulated product.
Two perspectives on the wider peptide conversation. These episodes provide context; they do not identify or validate a product with this label. Pick a thumbnail to watch here.
Huberman Lab · 1 April 2024
A useful starting point for the peptide conversation. Andrew Huberman talks through repair-related peptides, growth-hormone pathways and PT-141, alongside sourcing, side effects and the limits of the evidence. Listen for the difference between a promising idea and a result tested in people.
Play loads the YouTube player. Podcast discussion is context, not medical advice.
Huberman Lab · 1 June 2026
Why are peptides getting so much attention? Dr Abud Bakri joins Andrew Huberman to discuss BPC-157, GHK-Cu, melanotan and GLP-1 medicines. They explore what is being studied, why product sourcing matters and where animal findings still need to be tested in humans.
Play loads the YouTube player. Podcast discussion is context, not medical advice.